Search Within

Steven Maron

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (16)
  3. Conference Paper (1)
  4. Correspondence (1)
  5. Miscellaneous (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (37)
  2. Gastrointestinal Oncology Service (37)
  3. Sloan Kettering Institute Postdocs (37)
  4. Solid Tumor Oncology Division (37)
  5. Epidemiology and Biostatistics (32)
  6. Survivorship Research (29)

More Groups

People
  1. Yelena Janjigian (24)
  2. Geoffrey Ku (21)
  3. David Ilson (17)
  4. Nikolaus Schultz (17)
  5. Laura Tang (16)
  6. Vivian Strong (14)

More People

Years
  1. 2025 (3)
  2. 2024 (3)
  3. 2023 (11)
  4. 2022 (10)
  5. 2021 (7)
  6. 2020 (1)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Annals of Surgery (5)
  3. Annals of Surgical Oncology (5)
  4. Cancer Research (3)
  5. Clinical Cancer Research (3)
  6. Annals of Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (8)
  2. American Association for Cancer Research (7)
  3. Springer (6)
  4. Lippincott Williams & Wilkins (5)
  5. Elsevier Inc. (4)
  6. American Medical Association (2)

More Publishers

Results (37)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TMB cut-offs fail to predict benefit of PD-1 blockade in gastroesophageal adenocarcinoma in KEYNOTE-061
    Correspondence

    Foote, M. B.; Maron, S. B.; Cercek, A.; Argilés, G.; Rousseau, B.; Diaz, L. A. Jr
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Next-generation sequencing of 487 esophageal adenocarcinomas reveals independently prognostic genomic driver alterations and pathways
    Journal Article

    Sihag, S.; Nussenzweig, S. C.; Walch, H. S.; Hsu, M.; Tan, K. S.; Sanchez-Vega, F.; Chatila, W. K.; De La Torre, S. A.; Patel, A.; Janjigian, Y. Y.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • The interaction between microsatellite instability high (MSI-high) gastric cancer and chemotherapy on survival
    Meeting Abstract

    Vos, E. L.; Maron, S. B.; Krell, R. W.; Nakauchi, M.; Fiasconaro, M.; Walch, H. S.; Capanu, M.; Ku, G. Y.; Ilson, D. H.; Janjigian, Y. Y.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • The spectrum of benefit from checkpoint blockade in hypermutated tumors
    Research Letter

    Rousseau, B.; Foote, M. B.; Maron, S. B.; Diplas, B. H.; Lu, S.; Argilés, G.; Cercek, A.; Diaz, L. A. Jr
    New England Journal of Medicine (2021)

    Fulltext@MSK | Save
  • PET-directed chemoradiation (CRT) with induction FOLFOX compared to induction carboplatin/paclitaxel (CP) in patients with locally advanced esophageal adenocarcinoma (EA)
    Meeting Abstract

    Carr, R.; Hsu, M.; Tan, K. S.; Bains, M. S.; Bott, M.; Ilson, D. H.; Isbell, J. M.; Janjigian, Y. Y.; Maron, S. B.; Park, B.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S.; Chou, J. F.; Gabler, A. R.; Simmons, M. Z.; Momtaz, P.; Shcherba, M.; Ku, G. Y.; Won, E.; Sanchez-Vega, F.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save